WHO Model List
albendazole
International nonproprietary name (English: albendazole). Brand names vary by country.
Indications retained by WHO
Echinococcosis, cysticercosis, ascariasis, trichuriasis, hookworm diseases, enterobiasis and lymphatic filariasis.
Listed forms and strengths
- Oral > Solid > tablet: 400 mg (chewable, scored)
- Oral > Solid > tablet: 200 mg (chewable) (cysticidal, section 6.1.4)
Forms retained in the model list; presentations available in each country may differ.
General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.
Source: WHO electronic Essential Medicines List (2025 edition), checked on 13/11/2026. An error or an imprecision? Let us know